USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke DOPASTATIN wurde als Wortmarke am 22.11.2002 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 24.08.2004 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wortmarke |
| Aktenzeichen | 78187797 |
| Registernummer | 2877062 |
| Anmeldedatum | 22. November 2002 |
| Veröffentlichungsdatum | 16. März 2004 |
| Eintragungsdatum | 24. August 2004 |
Markeninhaber
65 QUAI GEORGES GORSE
92100 BOULOGNE-BILLANCOURT
FR
92100 BOULOGNE-BILLANCOURT
FR
Markenvertreter
Waren und Dienstleistungen
1
Chemicals for use in the manufacture of pharmaceutical preparations
5
Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases; laxatives and purgative agents; pharmaceutical preparations for use in the treatment of cardiovascular diseases; pharmaceutical preparations for use in the treatment pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical preparations for use in the treatment of urological diseases;pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations comprising peptides for hormonal treatment and tumor treatment; pharmaceutical preparations for use in the treatment of endocrine disorders; pharmaceutical preparations for use in the treatment of acromegalia and carcinoid tumors; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for use in the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for use in the treatment of age-related disorders; pharmaceutical preparations for use in the treatment of diabetes, diabetes-related disorders; pharmaceutical preparations for use in the treatment of respiratory disorders; pharmaceutical preparations for use in the treatment of ophthalmological disorders; pharmaceutical preparations against cough; pharmaceutical preparations for use in the treatment of vertigo, nausea, vomiting and migraine; pharmaceutical preparations for use in the treatment of disorders and diseases of the reproductive system; pharmaceutical preparations for use in the treatment of glabellar lines, facial wrinkles, asymetries and defects and conditions of the human skin; and Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases; veterinary laxatives and purgative agent; veterinary preparations for use in the treatment of cardiovascular diseases; veterinary preparations for use in the treatment of circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of blood diseases; and veterinary preparations for use in the treatment of muscle disorders
42
Research and development services for chemical and pharmaceutical products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1378187797